AdvisorShares Psychedelics ETF (PSIL)
$21.85
▼ -0.21 (-0.95%)
1-day change
$15.64 – $27.02
52-week range
Holdings data is not available for this fund yet.
PSIL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -11.97% | ▼ -11.97% |
| 3M | ▼ -5.94% | ▼ -5.94% |
| 6M | ▲ +26.81% | ▲ +26.81% |
| YTD | ▲ +27.26% | ▲ +27.26% |
| 1Y | ▲ +11.20% | ▲ +21.26% |
| 3Y | ▲ +36.48% | ▲ +53.92% |
| 5Y | ▼ -75.65% | ▼ -71.96% |
| Max | ▼ -78.11% | ▼ -74.79% |
Volatility 1Y40.11%
Volatility 3Y58.16%
Max drawdown 3Y
-56.57%
Beta 3Y0.73
Sharpe 1Y*0.47
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jun 2026)
+$4.1M
Quarter ending Jun 2026
+$14.5M
Trailing 12 months
+$22.3M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 32 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| DEFINIUM THERAPEUTICS INC | 24477V105 | $5.7M | 12.85 | 121,381 | EC | CA |
| COMPASS PATHWAYS PLC | 20451W101 | $5.1M | 11.45 | 359,647 | EC | GB |
| ATAIBECKLEY INC | 04650F101 | $4.7M | 10.47 | 882,892 | EC | US |
| RELMADA THERAPEUTICS INC | 75955J402 | $3.0M | 6.84 | 438,901 | EC | US |
| NRX PHARMACEUTICALS INC | 629444209 | $2.7M | 6.07 | 659,018 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $1.9M | 4.38 | 11,553 | EC | US |
| CYBIN INC | 23256X407 | $1.9M | 4.35 | 292,711 | EC | CA |
| GH RESEARCH PLC | · | $1.9M | 4.31 | 71,267 | EC | IE |
| ALKERMES PLC | · | $1.9M | 4.30 | 36,438 | EC | IE |
| ALTO NEUROSCIENCE INC | 02157Q109 | $1.9M | 4.20 | 70,748 | EC | US |
| ABBVIE INC | 00287Y109 | $1.8M | 4.14 | 7,318 | EC | US |
| BLACKROCK TREASURY TRUST | · | $1.8M | 3.97 | 1,763,357 | STIV | US |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | $1.7M | 3.84 | 24,274 | EC | CA |
| JOHNSON & JOHNSON | 478160104 | $1.6M | 3.61 | 6,308 | EC | US |
| DREY INST PREF GOV MM-M | · | $1.4M | 3.10 | 1,378,957 | STIV | US |
| SUPERNUS PHARMACEUTICALS INC | 868459108 | $1.3M | 2.89 | 27,618 | EC | US |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | $1.1M | 2.49 | 252,909 | EC | US |
| NEURONETICS INC | 64131A105 | $966K | 2.17 | 742,795 | EC | US |
| QUANTUM BIOPHARMA LTD | 74764Y205 | $737K | 1.66 | 203,564 | EC | CA |
| OPTIMI HEALTH CORP | 68405H308 | $523K | 1.18 | 102,794 | EC | CA |
| PASITHEA THERAPEUTICS CORP | 70261F202 | $483K | 1.09 | 937,550 | EC | US |
| SILO PHARMA INC | 82711P300 | $469K | 1.06 | 75,582 | EC | US |
| PSYENCE BIOMEDICAL LTD | 74449F407 | $374K | 0.84 | 122,184 | EC | CA |
| INCANNEX HEALTHCARE INC | 45333F208 | $229K | 0.52 | 60,868 | EC | US |
| NUMINUS WELLNESS INC | 67054W103 | $209K | 0.47 | 8,482,082 | EC | CA |
| IGC PHARMA INC | 45408X308 | $185K | 0.42 | 678,480 | EC | US |
| VISTAGEN THERAPEUTICS INC | 92840H400 | $99K | 0.22 | 438,643 | EC | US |
| ENVERIC BIOSCIENCES INC | 29405E505 | $49K | 0.11 | 35,417 | EC | US |
| CLEARMIND MEDICINE INC | 185053600 | $3K | 0.01 | 1,169 | EC | CA |
| QUANTUM BIOPHARMA | · | $0 | 0.00 | 46,617 | EC | CA |
| SAGE THERAPEUTICS INC | · | $0 | 0.00 | 89,780 | EC | US |
| UNBUZZD WELLNESS INC | 90429T100 | $0 | 0.00 | 263,236 | EC | CA |
Dividends 8 payments
7.71%TTM yield
$1.68TTM payout / share
Quarterly
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 22, 2025 | $1.6840 |
| Sept. 22, 2025 | $0.0200 |
| June 23, 2025 | $0.0120 |
| March 21, 2025 | $0.1630 |
| Dec. 23, 2024 | $0.0550 |
| Sept. 23, 2024 | $0.1090 |
| Sept. 25, 2023 | $0.0300 |
| Sept. 26, 2022 | $0.5400 |
Institutional owners (13F) 21 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| CIBC Bancorp USA Inc. | $712,457 | 29.65% | 29,624 | Shares | June 30, 2026 |
| CIBC Private Wealth Group LLC | $474,823 | 19.76% | 25,019 | Shares | Sept. 30, 2025 |
| Belvedere Trading LLC | $359,042 | 14.94% | 14,929 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $305,651 | 12.72% | 12,709 | Shares | June 30, 2026 |
| Vigilare Wealth Management | $211,640 | 8.81% | 8,800 | Shares | June 30, 2026 |
| TRUIST FINANCIAL CORP | $205,452 | 8.55% | 8,543 | Shares | June 30, 2026 |
| Belvedere Trading LLC | $40,885 | 1.70% | 1,700 | Call option | June 30, 2026 |
| Belvedere Trading LLC | $21,645 | 0.90% | 900 | Put option | June 30, 2026 |
| Farther Finance Advisors, LLC | $18,175 | 0.76% | 756 | Shares | June 30, 2026 |
| Versant Capital Management, Inc | $17,775 | 0.74% | 790 | Shares | Sept. 30, 2026 |
| MORGAN STANLEY | $9,596 | 0.40% | 399 | Shares | June 30, 2026 |
| FIDUCIARY FINANCIAL ADVISORS | $7,215 | 0.30% | 300 | Shares | June 30, 2026 |
| MCGUIRE CAPITAL ADVISORS INC | $6,878 | 0.29% | 286 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $4,810 | 0.20% | 200 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $3,000 | 0.12% | 111 | Shares | June 30, 2026 |
| NATIONAL BANK OF CANADA /FI/ | $1,918 | 0.08% | 82 | Shares | June 30, 2026 |
| HOLLENCREST CAPITAL MANAGEMENT | $914 | 0.04% | 38 | Shares | June 30, 2026 |
| Allworth Financial LP | $530 | 0.02% | 22 | Shares | June 30, 2026 |
| Axiom Investment Management LLC | $241 | 0.01% | 10 | Shares | June 30, 2026 |
| CWM, LLC | $51 | 0.00% | 3 | Shares | March 31, 2026 |
| JPMORGAN CHASE & CO | $25 | 0.00% | 1 | Shares | June 30, 2026 |